Cited by 605Palliative Care and End-of-Life IssuesPalliative and Oncologic CareChronic Obstructive Pulmonary Disease (COPD) Research

An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial

Open access
Higginson, Irene J, Bausewein, Claudia, Reilly, Charles C, Gao, Wei, Gysels, Marjolein, Dzingina, Mendwas, McCrone, Paul, Booth, Sara +2 more·2014·The Lancet Respiratory Medicine

Abstract

BACKGROUND: Breathlessness is a common and distressing symptom, which increases in many diseases as they progress and is difficult to manage. We assessed the effectiveness of early palliative care integrated with respiratory services for patients with advanced disease and refractory breathlessness. METHODS: In this single-blind randomised trial, we enrolled consecutive adults with refractory breathlessness and advanced disease from three large teaching hospitals and via general practitioners in South London. We randomly allocated (1:1) patients to receive either a breathlessness support service or usual care. Randomisation was computer generated centrally by the independent Clinical Trials Unit in a 1:1 ratio, by minimisation to balance four potential confounders: cancer versus non-cancer, breathlessness severity, presence of an informal caregiver, and ethnicity. The breathlessness support service was a short-term, single point of access service integrating palliative care, respiratory medicine, physiotherapy, and occupational therapy. Research interviewers were masked as to which patients were in the treatment group. Our primary outcome was patient-reported breathlessness mastery, a quality of life domain in the Chronic Respiratory Disease Questionnaire, at 6 weeks. All analyses were by intention to treat. Survival was a safety endpoint. This trial is registered with ClinicalTrials.gov, number NCT01165034. FINDINGS: Between Oct 22, 2010 and Sept 28, 2012, 105 consenting patients were randomly assigned (53 to breathlessness support service and 52 to usual care). 83 of 105 (78%) patients completed the assessment at week 6. Mastery in the breathlessness support service group improved compared with the control (mean difference 0·58, 95% CI 0·01-1·15, p=0·048; effect size 0·44). Sensitivity analysis found similar results. Survival rate from randomisation to 6 months was better in the breathlessness support service group than in the control group (50 of 53 [94%] vs 39 of 52 [75%]) and in overall survival (generalised Wilcoxon 3·90, p=0·048). Survival differences were significant for patients with chronic obstructive pulmonary disease and interstitial lung disease but not cancer. INTERPRETATION: The breathlessness support service improved breathlessness mastery. Our findings provide robust evidence to support the early integration of palliative care for patients with diseases other than cancer and breathlessness as well as those with cancer. The improvement in survival requires further investigation. FUNDING: UK National Institute for Health Research (NIHR) and Cicely Saunders International.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2213-2600(14)70226-7

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Breathlessness services providing predominantly non-pharmacological approaches are effective, cost-effective, and improve distress from breathlessness, mastery, quality of life, and survival.

    “Such services provide a brief, cost-effective intervention that impacts positively on distress from breathlessness, mastery, quality of life, and even survival.”

    From The Breathing, Thinking, Functioning clinical model: a proposal to facilitate evidence-based breathlessness management in chronic respiratory disease (2017) · cites this paper as [26]

    The Summary (p. 2) reports improved breathlessness mastery and better survival in the service group, while cautioning that the survival finding needs further investigation. The Results (pp. 6–7) report no significant between-group differences in other patient-reported outcomes, including quality of life, and no significant difference in formal care costs. The paper therefore supports mastery and an exploratory survival finding, but does not establish improved breathlessness distress or quality of life relative to usual care, or demonstrate cost-effectiveness. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

2 retracted

Flagged first, then by citations

1 of the 44 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Higginson, I. J., Bausewein, C., Reilly, C. C., Gao, W., Gysels, M., Dzingina, M., McCrone, P., Booth, S., Jolley, C. J., & Moxham, J.
Affiliations
  • King's College London (GB)
  • Cambridge University Hospitals NHS Foundation Trust (GB)
Venue
The Lancet Respiratory Medicine
Publisher
Elsevier BV
Published
2014-12
Volume
2
Issue
12
Pages
979-987
ISSN
2213-2600 (ISSN-L)
OpenAlex
W2098206882
Cited by
605
References
44
Citations by year
2026: 23 · 2025: 36 · 2024: 36 · 2023: 47 · 2022: 46 · 2021: 68 · 2020: 51 · 2019: 68 · 2018: 64 · 2017: 69 · 2016: 57 · 2015: 39 · 2014: 1
FWCI
54.89
Type
journal article
Language
en
Open access
Locations
  • The Lancet Respiratory Medicine (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UvA-DARE (University of Amsterdam) (publishedVersion, other-oa)
  • UvA-DARE (University of Amsterdam) (submittedVersion, other-oa)
  • Research Portal (King's College London) (submittedVersion, cc-by)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Funders
  • Research for Patient Benefit (PBPG-0808-17311)
  • NIHR under its Research for Patient Benefit (RfPB) programme (PB-PG-0808-17311)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Palliative Care and End-of-Life Issues
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Palliative and Oncologic Care
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Keywords
refractory breathlessness, palliative care, advanced disease, chronic obstructive pulmonary disease, interstitial lung disease, survival, quality of life, physiotherapy, occupational therapy, early integration of palliative care, symptom management, usual care comparison, informal caregivers, ethnicity, Chronic Respiratory Questionnaire
MeSH terms
Adult, Chronic Disease, Dyspnea, Heart Failure, Humans, Palliative Care, Quality of Life, Respiratory Therapy, Single-Blind Method, Motor Neuron Disease, Treatment Outcome, Lung Diseases, Interstitial, Pulmonary Disease, Chronic Obstructive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review